Mr. Charles L. Orr Appointed New CEO at Immunotec
5/17/2013 8:47:10 AM
More...
|
Immunotec's Mr. Robert M. Henry Departs as CEO
5/13/2013 7:22:44 AM
More...
|
Immunotec Announces Closing $3.45 Million of New Financing
9/16/2011 6:35:22 AM
More...
|
Immunotec and Nova Southeastern University (NSU) Collaborate on New Autism Study using Immunocal®
7/26/2011 11:52:13 AM
More...
|
Immunotec Release: Important New Research using Immunocal® Shows Promise in Lou Gehrig's Disease
6/14/2011 10:23:49 AM
More...
|
Immunotec CEO to Retire at the End of the Year
12/9/2010 11:20:28 AM
More...
|
Immunotec Announces Stock Option Grant
11/15/2010 8:25:25 AM
More...
|
Immunotec Grants Options to Directors and Officers
3/31/2010 2:34:09 PM
More...
|
Immunotec Announces Positive First-Quarter Results and the Return to Profitability
3/29/2010 11:23:27 AM
More...
|
Immunotec Announces the Closing of its Korean Operations
8/3/2009 7:48:30 AM
More...
|
|